Align Technology, Inc.

Align Technology, Inc.

ALGN

$154.13

Updated: 03/11/2026, 09:12:07

Market Cap
$10.95B
Sector
Healthcare
Industry
Medical - Devices
Country
US

No historical data available

Company Profile

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

USD
NASDAQ
CEO: Joseph Hogan
Employees: 20,290
https://www.aligntech.com
Asset Summaries
Latest generated summaries for ALGN

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
ALGN-10-k-fy2025.html2.3 MBtext/htmlENFiled 27/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 66 KPI observations

Revenue

$4.0B

FY 2025 · Reported

Net income

$0.4B

FY 2025 · Reported

Gross margin

67.2%

FY 2025 · Calculated

Free cash flow

$0.5B

FY 2025 · Calculated

R&D intensity

9.2%

FY 2025 · Calculated

Share repurchases

$0.5B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Invisalign clear aligner system
exocad CAD/CAM software platform
Invisalign Outcome Simulator Pro
iTero Design Suite
iTero intraoral scanners and digital dentistry platform

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Cumulative patients treated

Over past 28 years, Align has helped doctors treat over 22 million patients with the Invisalign System

95%
Source evidence
“Over the past 28 years, Align has helped doctors treat over 22 million patients with the Invisalign System”

DSO ecosystem partnerships

DSOs represent a large and growing opportunity; Align has well established relationships with many DSOs globally and may financially invest in or collaborate with them

90%
Source evidence
“DSOs represent a large and growing opportunity to help drive adoption of digital technology across the dental industry.”

Use of non-exclusive distributors and commercial intermediaries

Distributors, resellers and other commercial intermediaries used alongside direct sales force; generally non-exclusive agreements

95%
Source evidence
“In addition to our direct sales force, we have and expect to continue to use distributors, resellers or other commercial intermediaries to import, market, sell, service and support our products and services.”

Invisalign clear aligner system

Invisalign clear aligners and related treatment products depart from traditional orthodontic wires and brackets

95%
Source evidence
“Invisalign treatment is a significant departure from traditional orthodontic wires and brackets”

exocad CAD/CAM software platform

exocad CAD/CAM software addresses restorative needs; licensed and sold separately to doctors and dental labs

95%
Source evidence
“Our exocad CAD/CAM software platform addresses restorative needs in an end-to-end digital platform workflow to facilitate ortho-restorative and comprehensive dentistry.”

Invisalign Outcome Simulator Pro

Chairside simulation tool generating simulated in-face visualizations of potential future smile; ortho-only and ortho-restorative (Smile Architect) simulations; Smile Video dynamic visualization

95%
Source evidence
“Invisalign Outcome Simulator Pro is a patient communication tool on iTero Element™ Plus Series and iTero Lumina™ imaging systems, that generates highly realistic, simulated in-face visualizations of a patient's potential future smile”

iTero Design Suite

Chairside design workflow for 3D printing and milling of models, bite splints, mock-ups, restorations for single-visit dentistry

95%
Source evidence
“iTero™ Design Suite offers doctors and dental staff a simple and intuitive digital chairside design workflow for 3D printing and milling of models, bite splints, mock-ups, and restorations to enable single-visit dentistry”

iTero intraoral scanners and digital dentistry platform

iTero intraoral scanners plus digital CAD/dental platform products

90%
Source evidence
“our clear aligners and iTero products utilize digital technology and some dental professionals have and may continue to resist moving to a digital platform”

Operations and dependencies

Significant foreign currency exposure

Large portion of net revenues and expenses in foreign currencies; FX forwards used but may not eliminate exposure

90%
Source evidence
“a large portion of our net revenues and expenses are generated in foreign currencies”

Clear aligner manufacturing in Mexico serving US customers

Clear aligners manufactured in Mexico facility, shipped primarily to US customers

95%
Source evidence
“we manufacture clear aligners in our facility in Mexico and ship them to the United States, primarily for our United States customers, with the remainder eventually shipped to other international locations”

Regional fabrication facilities for clear aligners

Clear aligner fabrication in Juarez Mexico, Ziyang China, and Wroclaw Poland; 11 fabrication and treatment planning locations; selling in more than 100 countries

95%
Source evidence
“We have regional fabrication facilities in our main markets for clear aligners, which are located in Juarez, Mexico; Ziyang, China; and Wroclaw, Poland.”

Scanner production and treatment planning locations

Scanner wands produced and final assembly in Ziyang China and Petah Tikva Israel plus Blonie Poland and Juarez Mexico; digital treatment planning in Costa Rica, China, Germany, Spain, Poland, Japan

95%
Source evidence
“We produce our handheld intraoral scanner wand, perform final scanner assembly and repair our scanners at our facilities in Ziyang, China and Petah Tikva, Israel and also perform final scanner assembly in Blonie, Poland and Juarez, Mexico”

Dependence on UPS as primary freight carrier

Primary freight carrier: United Parcel Service, Inc.

95%
Source evidence
“We depend on commercial freight carriers, primarily United Parcel Service, Inc., to deliver our products.”

High dependence on third-party and sole-source suppliers

Highly dependent on third-party suppliers, some sole source, for key machines, components and materials; single/sole supply relationships in limited locations

95%
Source evidence
“We are highly dependent on our supply chain, particularly manufacturers of specialized and customized scanning equipment, rapid prototyping machines, resin and other advanced materials, as well as the optics, electronic and other mechanical components of our iTero scanners.”

Approximately 91% of employees located internationally

~91% of employees located internationally; immigration policies may affect talent retention

95%
Source evidence
“Additionally, approximately 91% of our employees are located internationally, and restrictive immigration or travel policies or legal or regulatory developments relating to immigration in the United States and other countries may negatively affect our efforts to attract, motivate, train or retain qualified personnel.”

Positioning and strategy

Teen and younger market opportunity

Teenage and younger market is ~70% of estimated 22 million annual global orthodontic case starts; 2025 saw record teen/kid Invisalign treatment starts

90%
Source evidence
“the teenage and younger market makes up approximately 70% of the estimated 22 million total annual global orthodontic case starts”

Macro conditions drive elective procedure demand

Consumer discretionary spending drives clear aligner demand; downturns cause reversion to wires and brackets

90%
Source evidence
“decreased demand for dental services has and may in the future cause doctors and labs to revert to wires and brackets and postpone investments in capital equipment”

AI investment and governance

Investing in AI infrastructure, talent and partnerships to enhance the Align Digital Platform, drive automation and capital efficiency, with responsible AI governance frameworks

90%
Source evidence
“we continue to invest in AI infrastructure, specialized talent, and strategic partnerships to further enhance the capabilities of the Align™ Digital Platform”

International expansion and digital dentistry strategy

International market expansion and digital dentistry are stated strategic focus areas

70%
Source evidence
“our expectations regarding the continued expansion of our international markets and their growth”

Risks, financing, and outlook

Inflation, energy, shipping, raw materials and labor costs

Inflation, fuel/energy, shipping, raw material and labor costs pressure cost of production and shipping

90%
Source evidence
“the cost of fuel, energy and domestic and international shipping costs, food and other essential or discretionary items, raw material prices and labor rates, has and may continue to rise”

Freight and fuel costs pressure gross margin

Rising fuel/freight costs and higher-cost international shipments pressure gross margin

90%
Source evidence
“when fuel costs increase, our freight costs generally do as well. In addition, we earn an increasingly larger portion of our total revenues from international sales, which carry higher shipping costs that negatively impact our gross margin”

Tariff and trade war exposure by country

Government tariff actions in US, China, Europe, Brazil, Canada, Israel, Mexico may hurt revenue and COGS; US-China trade war may limit availability of raw materials and parts

90%
Source evidence
“we believe government actions relating to actual or proposed tariffs and retaliatory actions in key strategic countries or regions, particularly in the United States, China, Europe, Brazil, Canada, Israel and Mexico may adversely impact our revenue and cost of goods sold”

International revenue growth expectation

Over the longer-term, international revenues expected to grow faster than Americas' revenues due to growing demand, investment, market size and low penetration

90%
Source evidence
“Over the longer-term, we expect international revenues to grow faster than Americas' revenues as a result of growing international demand”

Forward-looking macro assumption set

Management outlook embedded in macro assumptions: FX, inflation, rates, tariffs, recessions, geopolitical events

75%
Source evidence
“our beliefs and expectations regarding macroeconomic conditions, including fluctuations in foreign currency exchange rates, inflation, higher interest rates, market volatility, actual or proposed tariffs”

Antitrust and competition investigations and enforcement

Subject to antitrust/competition investigations and enforcement; potential fines, consent decrees and business practice restrictions

90%
Source evidence
“We currently are and may in the future be subject to antitrust, competition or unfair competition-related investigations, enforcement actions or claims by governmental agencies, competitors, consumers, customers and others”

Quality system regulation compliance

Quality system must comply with FDA Quality System regulations; certified to ISO 13485:2016; routinely audited

90%
Source evidence
“Our quality system is required to be in compliance with the Quality System regulations enforced by the FDA ... We are certified to ISO 13485:2016”

Clear aligner production dependent on installed base of iTero and third-party scanners

Clear aligner production dependent on scans from globally dispersed installed base of iTero and third-party intraoral scanners

95%
Source evidence
“A significant portion of our clear aligner production is dependent on digital scans from our globally dispersed and decentralized installed base of iTero and third-party intraoral scanners”

Tariff and trade policy exposure

Section 232 investigation into medical equipment imports; tariffs may increase costs and hurt gross margin

90%
Source evidence
“the U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962”

Marketing dependence on third-party mobile platforms

Ad targeting/measurement dependent on Android, iOS and mobile browsers not controlled by Align

90%
Source evidence
“we are dependent on third parties and popular mobile operating systems, networks, technologies, products and standards we do not control, such as the Android and iOS operating systems, and mobile browsers”

Macro/trade headwinds in 2025

Q2 2025 sales adversely impacted by tariff volatility, inflation, higher interest rates; orthodontic starts down four consecutive years; shift to wires and brackets

90%
Source evidence
“we believe that in the beginning of the second quarter of 2025, sales of our products were adversely impacted compared to the same period in prior years by certain macroeconomic conditions, including global tariff volatility, inflation, and higher interest rates”

Stock price volatility and concentrated ownership

Volatile stock price; significant percentage of shares owned by a small number of stockholders

90%
Source evidence
“A significant percentage of our outstanding common stock is currently owned by a small number of stockholders.”

Works councils and trade unions in certain countries

Employees represented by works councils/trade unions in certain countries; labor dispute risk

90%
Source evidence
“We have personnel represented by works councils and trade unions in certain countries”

Marketing restrictions on medical device direct-to-consumer advertising

Many countries prohibit direct-to-consumer advertising of medical devices; past allegations of marketing restriction violations

90%
Source evidence
“many countries prohibit certain types of marketing activities, such as direct to consumer advertising of medical devices. We have and may in the future be alleged to violate marketing restrictions”

Climate change and natural disaster risk to facilities and supply chain

Climate-driven natural disasters could disrupt facilities, suppliers, energy and manufacturing

85%
Source evidence
“Climate change could increase the frequency and severity of natural disasters such as hurricanes, tornadoes, earthquakes, wildfires, droughts, extreme temperatures, or flooding”

Adoption resistance and competitive reputation spillover

Dental professional adoption resistance; competitor product failures could harm demand via category reputation

85%
Source evidence
“negative experiences with clear aligner products manufactured or distributed by competitors may adversely affect our reputation and demand for the Invisalign System”

Material exposure graph

iTero and third-party intraoral scanners
Revenue Exposure

Clear aligner production depends on digital scans from the installed base of iTero and third-party scanners; loss of scanner support or interoperability failures would directly impair aligner revenues.

Relevance 90·Dependency 85·Confidence 95
Source evidence
“if we or third parties discontinue commercial availability or support for older versions of these scanners, our clear aligner revenues could be adversely impacted”
Consumer discretionary spending
Demand Driver

Clear aligners are elective procedures; macro weakness reduces case starts and dental practice spending.

Relevance 85·Dependency 80·Confidence 90
Source evidence
“Macroeconomic conditions impact consumer confidence and discretionary spending, which can reduce or shift spending away from elective procedures”
consumer_spending
Demand Driver

Invisalign treatment is discretionary; revenues fluctuate with consumer sentiment, discretionary spending, inflation and interest rates.

Relevance 85·Dependency 70·Confidence 90
Source evidence
“Our revenues may fluctuate as a result of events and circumstances impacting customer confidence, consumer sentiment, discretionary spending and ultimately demand for dental services and our products”
tariffs
Revenue Exposure

Tariff volatility and retaliatory trade measures in key markets adversely impacted 2025 sales and may affect revenue and cost of goods sold.

Relevance 85·Dependency 60·Confidence 90
Source evidence
“sales of our products were adversely impacted compared to the same period in prior years by certain macroeconomic conditions, including global tariff volatility, inflation, and higher interest rates”
clear aligner fabrication facilities
Manufacturing Dependency

Clear aligner production depends on three regional fabrication facilities (Juarez, Ziyang, Wroclaw) that provide proximity to customers and production flexibility.

Relevance 80·Dependency 75·Confidence 90
Source evidence
“We have regional fabrication facilities in our main markets for clear aligners, which are located in Juarez, Mexico; Ziyang, China; and Wroclaw, Poland.”
Tariffs and trade protectionism
Competitive Exposure

Tariffs and retaliatory measures may increase costs, reduce demand and pressure gross margin given foreign manufacturing/sourcing.

Relevance 80·Dependency 70·Confidence 85
Source evidence
“Tariffs have and could in the future result in additional costs for our products, which may reduce demand for our products and adversely impact our gross margin”
Section 232 investigation on medical equipment imports
Regulatory Exposure

Section 232 investigation covering medical equipment could raise costs of products sourced outside the US.

Relevance 80·Dependency 70·Confidence 85
Source evidence
“imports of personal protective equipment (PPE), medical consumables, and medical equipment including devices”
United Parcel Service, Inc.
Supplier Dependency

UPS is the primary freight carrier delivering Align's products; disruptions or freight/fuel cost increases would hit revenue delivery and gross margin.

Relevance 75·Dependency 80·Confidence 95
Source evidence
“We depend on commercial freight carriers, primarily United Parcel Service, Inc., to deliver our products.”
teen patient demographics
Demand Driver

Teens and growing patients represent ~70% of the estimated 22 million annual global orthodontic case starts; record teen/kid treatment starts in 2025 support utilization growth.

Relevance 75·Dependency 60·Confidence 90
Source evidence
“the teenage and younger market makes up approximately 70% of the estimated 22 million total annual global orthodontic case starts”
us_china_tensions
Geopolitical Exposure

US-China trade war may limit availability of raw materials, components and parts necessary for Align's products or its suppliers' products; geopolitical conflicts dampen consumer sentiment.

Relevance 75·Dependency 55·Confidence 85
Source evidence
“The trade war and geopolitical tensions between the United States and China may result in the limitation or prohibition of the availability of certain raw materials, components and parts necessary for our products”
Global supply chain disruption
Supplier Dependency

Products and components/raw materials largely manufactured or sourced outside the US; geopolitical events can disrupt supply chains and shipping.

Relevance 70·Dependency 65·Confidence 80
Source evidence
“A significant portion of the products we sell, and the components and raw materials used in our products are originally manufactured or sourced outside the United States”
Foreign currencies (EUR and others)
Currency Exposure

Large portion of net revenues and expenses in foreign currencies against USD reporting currency; FX forwards used but incomplete hedge.

Relevance 70·Dependency 65·Confidence 75
Source evidence
“utilize foreign currency forward contracts to moderate the impact of currency fluctuations on certain assets and liabilities, these contracts may not eliminate our exposure”
dso
Customer Exposure

DSOs are a large and growing channel to drive digital technology adoption; Align may financially invest in or collaborate with DSOs.

Relevance 70·Dependency 45·Confidence 90
Source evidence
“We have and may continue to financially invest in or explore collaborations with key ecosystem partners, including DSOs”
fda_quality_system_regulation
Regulatory Exposure

Manufacturing must comply with FDA Quality System regulations and analogous global regulations; certified to ISO 13485:2016 with routine third-party and health authority audits.

Relevance 65·Dependency 60·Confidence 90
Source evidence
“Our quality system is required to be in compliance with the Quality System regulations enforced by the FDA, and similar regulations of other worldwide regulatory authorities.”
artificial_intelligence
Technology Dependency

AI investment differentiates the Align Digital Platform from competitors, unlocks adjacent markets, and drives automation across operations; proprietary AI/machine-learning based CAD/CAM software underpins manufacturing.

Relevance 65·Dependency 55·Confidence 85
Source evidence
“We believe our commitment to AI can unlock new and adjacent market opportunities, and sharpen our operational focus and capital efficiency by driving automation, scalability, and productivity across our operations”
Antitrust and competition regulations
Regulatory Exposure

Antitrust/competition investigations or enforcement could result in fines, consent decrees and business practice restrictions affecting revenues.

Relevance 60·Dependency 50·Confidence 90
Source evidence
“could cause us to incur substantial costs (including fines), enter into settlements or consent decrees, be subject to judgments”
OECD Pillar Two 15% global minimum tax
Tax Exposure

Pillar Two global minimum tax and other tax law changes (BEPS, One Big Beautiful Bill Act) could raise Align's effective tax rate and affect operations.

Relevance 55·Dependency 45·Confidence 85
Source evidence
“the OECD/G20 Framework's Pillar Two 15% global minimum tax, and the One Big Beautiful Bill Act”
Android and iOS operating systems
Technology Dependency

Marketing effectiveness and ad targeting rely on mobile OS data access; platform changes could degrade campaign performance or raise customer acquisition costs.

Relevance 50·Dependency 55·Confidence 90
Source evidence
“Changes in such systems that degrade or eliminate our ability to target or measure the results of ads or increase costs to target audiences could adversely affect our campaigns.”
Fuel/freight cost inflation
Cost Driver

Fuel cost increases drive freight costs higher and international shipments carry higher shipping costs, compressing gross margin if increases cannot be passed to customers.

Relevance 50·Dependency 45·Confidence 90
Source evidence
“If freight costs materially increase and we are unable to successfully pass all or significant portions of the increases along to our customers... our gross margin and financial results could be materially affected.”
Full company information
Latest profile, trading, valuation, and identifier data stored for ALGN.
Share price
$154.13
Market cap
$10.95B
Exchange
NASDAQ
Currency
USD
CEO
Joseph Hogan
Employees
20,290
IPO date
30/01/2001
Beta
1.673
Last dividend
$0.00
Day range
$150.28 – $154.69
52-week range
$130.23 – $200.44
1-day performance
2.83%
1-year performance
18.35%
Current drawdown (1Y)
-23.10%
CIK
0001097149
CUSIP
016255101
ISIN
US0162551016
Created
07/12/2025, 02:02:09
Last update
03/11/2026, 09:12:07

Track Align Technology, Inc. with an AI analyst

See which prediction-market events move ALGN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to ALGN from your Railway `news_articles` table.

Align Technology (ALGN) Just Overtook the 50-Day Moving Average

Zacks Investment Research • STOCK • 10/06/2026, 12:31:10

Align Technology, Inc. (ALGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 08/06/2026, 14:18:30

Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 04/06/2026, 16:32:55

Align Technology, Inc. (ALGN) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

Seeking Alpha • STOCK • 03/06/2026, 17:41:59

Align Technology Pitches AI-Powered Digital Dentistry Platform Beyond Invisalign

MarketBeat • STOCK • 03/06/2026, 14:02:31

Align Technology (ALGN) Down 1.6% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research • STOCK • 29/05/2026, 14:32:09

Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research • STOCK • 22/05/2026, 12:41:21

Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations

Business Wire • STOCK • 21/05/2026, 18:40:00

Reasons to Add Align Technology Stock to Your Portfolio Now

Zacks Investment Research • STOCK • 20/05/2026, 17:35:49

Why Align Technology (ALGN) is a Top Value Stock for the Long-Term

Zacks Investment Research • STOCK • 18/05/2026, 12:40:37

ALGN vs. WST: Which Stock Is the Better Value Option?

Zacks Investment Research • STOCK • 11/05/2026, 14:41:15

Align Technology Showcases Latest Advances in Integrated Digital Orthodontics and Previews 2026 Innovation at AAO Annual Session

Business Wire • STOCK • 30/04/2026, 16:55:00